½ÃÀ庸°í¼­
»óǰÄÚµå
1494852

¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø : Á¦Ç° À¯Çüº°, À¯Çüº°, ÄÄÆ÷³ÍÆ®º°, Àü°³ À¯Çüº°, ¼­ºñ½ºº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(-2030³â)

Medical Robotic System Market Forecasts to 2030 - Global Analysis By Product Type, Type, Component, Deployment Type, Service, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀåÀº 2024³â 299¾ï 7,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ µ¿¾È CAGRÀº 18.9%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 846¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹Ãø ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛÀº ±â¼ú°ú ÇコÄɾîÀÇ Çõ¸íÀûÀÎ À¶ÇÕÀ̸ç, Ä¡·áÀÇ ½Ç½Ã ¹æ¹ý°ú Ä¡·á ¹æ¹ýÀ» ¿ÏÀüÈ÷ ¹Ù²Ù´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü Àåºñ´Â ¿Ü°úÀǻ簡 º¹ÀâÇÑ ÀýÂ÷¸¦ Àΰ£º¸´Ù Á¤È®ÇÏ°í ¼Õ½±°Ô ó¸®ÇÒ ¼ö ÀÖ°Ô ÇÏ°í µ¿½Ã¿¡ ȯÀÚÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ·Îº¿Àº ÷´Ü ¼¾¼­, À̹Ì¡ ±â¼ú ¹× AI ¾Ë°í¸®Áò ´öºÐ¿¡ ¼¶¼¼ÇÑ ÇØºÎÇÐÀû ±¸Á¶¸¦ ºñ±³ÇÒ ¼ö ¾ø´Â Á¤È®µµ·Î Ž»öÇÒ ¼ö ÀÖ½À´Ï´Ù.

±¹Á¦·Îº¿¿¬¸Í(IFR)¿¡ µû¸£¸é ÀÇ·á¿ë ·Îº¿ÀÇ µµÀÔÀº ±Þ¼ÓÈ÷ È®´ëµÇ°í ÀÖÀ¸¸ç, 2020³â ¸»±îÁö ¼¼°è¿¡¼­ 1¸¸ 7,000´ëÀÇ ¼ö¼ú¿ë ·Îº¿ÀÌ µµÀ﵃ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.

Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡

ÅëÁõ ¿ÏÈ­, ÀÔ¿ø±â°£ ´ÜÃà, ȸº¹±â°£ ´ÜÃà, ÈäÅͰ¡ ³²±â ¾î·Á¿î ¼ÒÀý°³´Â Àúħ½À ¼ö¼úÀÌ °³º¹¼ö¼ú¿¡ ºñÇØ °¡Áö´Â ÀåÁ¡ Áß ÀϺο¡ ºÒ°úÇÕ´Ï´Ù. ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â ÀÌÀ¯´Â ¿Ü°úÀǻ簡 º¸´Ù ³ôÀº Á¦¾î¿Í Á¤¹Ðµµ·Î ÀÌ·¯ÇÑ Á¶Ä¡¸¦ ÃëÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. °Ô´Ù°¡ ÀÇ·á°ü·ÃÀÚµéÀº º¸´Ù ·Îº¿ ħÀÔ ¼ö¼úÀ» ¿ä±¸Çϴ ȯÀÚÀÇ ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ ·Îº¿ Áö¿ø ¼ö¼ú ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ±× ¼ö´Â Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù.

°í°¡ÀÇ Ãʱ⠰¡°Ý

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛÀÇ ³ôÀº Ãʱ⠺ñ¿ëÀº º¸±ÞÀ» ¸·´Â ÁÖ¿ä Àå¾Ö Áß ÇϳªÀÔ´Ï´Ù. ÀÇ·á ½Ã¼³ÀÇ °æ¿ì ·Îº¿ ¼ö¼ú ½Ã½ºÅÛÀ» ±¸ÀÔÇÏ´Â µ¥ µå´Â Ãʱ⠺ñ¿ëÀº °ü·Ã ±³À° ¹× À¯Áö º¸¼ö ºñ¿ë ¿Ü¿¡µµ ¸¹Àº ºñ¿ëÀÌ µé ¼ö ÀÖ½À´Ï´Ù. Àü¹®ÀûÀÎ ÀÎÇÁ¶ó¿Í Á¤±âÀûÀÎ ¼ÒÇÁÆ®¿þ¾î ¾÷µ¥ÀÌÆ®°¡ ÇÊ¿äÇϹǷΠºñ¿ë ºÎ´ãÀÌ ´õ¿í Ä¿Áý´Ï´Ù. °Ô´Ù°¡ ÀÌ·¯ÇÑ ¾öû³­ ÁöÃâÀº ƯÈ÷ ¼Ò±Ô¸ð ÀÇ·á Á¦°ø¾÷ü¿Í ÀÚ¿ø¿¡ Á¦¾àÀ» ¹Þ´Â ȯ°æ¿¡¼­ ÀÏÇÏ´Â ÀÇ·á Á¦°ø¾÷ü¿¡°Ô ·Îº¿ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¸Á¼³ÀÌ°Ô ÇÏ´Â Å« ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½Å ¹× °úÇÐÀÇ Áøº¸

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀåÀº º¸´Ù ÀÛ°í °æÄèÇÑ ·Îº¿ Ç÷§Æû °³¹ß, À̹ÌÁö ¸ð´Þ¸®Æ¼ Çâ»ó, AI¸¦ Ȱ¿ëÇÑ ¼ö¼ú Áö¿ø µî ·Îº¿ ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ¸¹Àº °¡´É¼ºÀ» °®°í ÀÖ½À´Ï´Ù. ±â¼ú ±â¾÷, ÀÇ·á½Ã¼³, ¿¬±¸ ±×·ìÀÌ Çù·ÂÇÔÀ¸·Î½á, ÀÌ¹Ì »ç¿ëµÇ°í ÀÖ´Â ·Îº¿ Ç÷§ÆûÀÇ »õ·Î¿î ¿ëµµ¸¦ ¹ß°ßÇÏ°í °³·®Çϱ⠽¬¿öÁý´Ï´Ù. ¶ÇÇÑ, ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¼ú ¹æ¹ýÀÇ °­È­, ÀÇ·á¿ë ·Îº¿ÀÇ ´É·Â Çâ»ó, ½Å±Ô Ä¡·á ¿µ¿ªÀÇ Á¶»ç µîÀÇ ¿¬±¸°³¹ß(R&D) ÇÁ·ÎÁ§Æ®¿¡ ´ëÇÑ ÅõÀÚÀÇ °á°ú, ¹ßÀüÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå Æ÷È­ ¹× °æÀï

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀåÀº ´õ ¸¹Àº ±â¾÷µéÀÌ ½ÃÀå¿¡ ÁøÀÔÇÏ°í µ¿µîÇÑ ±â¼úÀ» Á¦°øÇÔÀ¸·Î½á °æÀïÀÌ Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ °ø±ÞÀÌ ¼ö¿ä¸¦ »óȸÇÏ´Â ½ÃÀå Æ÷È­ °¡´É¼ºÀÌ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. °¡°Ý °æÀï, ¼öÀÍ·ü °¨¼Ò, °ø±Þ¾÷ü ¹× Á¦Á¶¾÷üÀÇ ¼öÀͼº °¨¼Ò´Â ¸ðµÎ Ä¡¿­ÇÑ °æÀïÀÇ °á°úÀÔ´Ï´Ù. ¶ÇÇÑ, ÀϺΠÀü¹® ºÐ¾ß¿¡¼­ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛÀÇ ÀÌÁ¡Àº À̹ÌÁö À¯µµ ÁßÀç ¹× º¹°­°æ ¼ö¼ú°ú °°Àº ´ëü ¼ö¼ú ±â¼ú°ú ±â¼úÀÇ º¸±Þ¿¡ ÀÇÇØ À§ÇùµÇ°í ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀåÀº COVID-19ÀÇ À¯Çà¿¡ ÀÇÇØ ´Ù¾çÇÑ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÆÒµ¥¹ÍÀÇ Ãʱ⠴ܰ迡¼­´Â Á¦Á¶, °ø±Þ¸Á ¹°·ù ¹× ´ë±â ¼ö¼ú¿¡ È¥¶õÀÌ ¹ß»ýÇÏ¿© ½ÃÀå ¼ºÀåÀÌ ÀϽÃÀûÀ¸·Î µÐÈ­µÇ¾ú½À´Ï´Ù. ±×·¯³ª ·Îº¿ Áö¿ø ¼ö¼úÀÇ Ã¤¿ëÀº »çȸÀû °Å¸®¸¦ µÑ Çʿ伺°ú ±×¿¡ µû¸¥ °¨¿° ´ëÃ¥ Áß½ÃÀÇ °üÁ¡¿¡¼­ °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á½Ã¼³¿¡¼­´Â ¼ö¼ú Á¤¹Ðµµ Çâ»ó, ¹ÙÀÌ·¯½º °¨¿° À§ÇèÀÇ Àú°¨, °³ÀÎ º¸È£±¸ÀÇ º¸Àü µîÀ¸·Î ·Îº¿ ½Ã½ºÅÛÀÇ ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¼ÒÇÁÆ®¿þ¾î Ç÷§Æû ºÐ¾ß°¡ ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë°¡ µÉ Àü¸Á

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀåÀº ÀϹÝÀûÀ¸·Î ¼ÒÇÁÆ®¿þ¾î Ç÷§Æû ºÎ¹®ÀÌ Áö¹èÀûÀÔ´Ï´Ù. ÀÌ´Â µ¥ÀÌÅÍ Ã³¸®, ·Îº¿ µ¿ÀÛ Á¦¾î ¹× Çϵå¿þ¾î °£ Åë½ÅÀÌ ¸ðµÎ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛÀÇ ÇÙ½ÉÀ» ÀÌ·ç´Â ¼ÒÇÁÆ®¿þ¾î Ç÷§Æû¿¡ ÀÇÇØ °¡´ÉÇØÁö±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ Ç÷§ÆûÀº ÃÖ÷´Ü ¾Ë°í¸®Áò, ÀΰøÁö´É(AI), ¸Ó½Å·¯´× ±â´ÉÀ» »ç¿ëÇÏ¿© Á¤È®ÇÑ ¼ö¼ú Ž»ö, °èȹ ¹× ½ÇÇàÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀº ¿öÅ©Ç÷οì È¿À²¼º Çâ»ó, ·Îº¿ Áö¿ø ÀýÂ÷ Áß È¯ÀÚÀÇ ¾ÈÀü º¸Àå, »ç¿ëÀÚ °æÇè Çâ»ó¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ °¡Àå ³ôÀº CAGR ¿¹»ó

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå¿¡¼­´Â ÀϹÝÀûÀ¸·Î Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ °¡Àå CAGRÀÌ ³ô½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº È®À强, À¯¿¬¼º, ³»°Ô ÇÊ¿äÇÑ ¿É¼Ç µî ¸¹Àº ÀÌÁ¡À» Á¦°øÇϹǷΠÀÇ·á±â±â Á¦Á¶¾÷ü ¹× ÀÇ·á Á¦°ø¾÷ü¿¡°Ô ´õ¿í ¸Å·ÂÀûÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å¬¶ó¿ìµå ±â¹Ý ÀÇ·á ·Îº¿ ½Ã½ºÅÛÀº ½Ç½Ã°£ µ¥ÀÌÅÍ °øÀ¯, ¿ø°Ý ¸ð´ÏÅ͸µ, Çù¾÷ ¿öÅ©Ç÷ο츦 °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á »ý»ê¼º, ¿¬°á¼º ¹× ȯÀÚ °ü¸® Á¦°øÀ» °³¼±ÇÕ´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå¿¡¼­´Â ºÏ¹Ì°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÁ¡Àº Á¤±³ÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ Á¸Àç, ³ôÀº ÀÇ·áºñ, À¯¸®ÇÑ »óȯ °üÇà, ÀÇ·á ·Îº¿ ½Ã½ºÅÛÀÇ µµÀÔÀ» ÃËÁøÇÏ´Â °­·ÂÇÑ ±ÔÁ¦ ȯ°æ µîÀÇ ¿ä¼Ò¿¡ ±âÀÎÇÕ´Ï´Ù. °Ô´Ù°¡ ÀÌ Áö¿ªÀº ÇコÄɾî Á¦°ø¾÷ü, ¿¬±¸±â°ü, ±â¼ú ±â¾÷¿¡ ÀÇÇÑ °ß°íÇÑ »ýŰ踦 ÅëÇØ Çõ½Å°ú ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ºÎÀΰú, ÀÏ¹Ý ¿Ü°ú, ºñ´¢±â°ú µî ´Ù¾çÇÑ Àü¹® ºÐ¾ß¿¡¼­ ·Îº¿ Áö¿ø ¼ö¼úÀÌ ³Î¸® ÀÌ¿ëµÇ°í Àֱ⠶§¹®¿¡ ½ÃÀå¿¡¼­ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå¿¡¼­´Â ÀϹÝÀûÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ CAGRÀÌ °¡Àå ³ô½À´Ï´Ù. °í±Þ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ÀÇ·á ±â¼ú ÅõÀÚ, ºü¸£°Ô ¼ºÀåÇÏ´Â ÀÇ·á ÀÎÇÁ¶ó µîÀÌ ÀÌ·¯ÇÑ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. Áß±¹, ÀϺ», Çѱ¹, Àεµ¸¦ Æ÷ÇÔÇÑ ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ¸¸¼º Áúȯ Áõ°¡, ³ëÈ­ ¹× Àúħ½À ¼ö¼ú·ÎÀÇ ÀüȯÀ¸·Î ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àå·ÁÀûÀÎ Á¤ºÎ ÇÁ·Î±×·¥, µµ¿òÀÌ µÇ´Â ¹ý·ü, ÇØ¿Ü Á¦Á¶¾÷ü¿Í Áö¿ª °Ç°­ °ü¸® Á¦°ø¾÷ü¿ÍÀÇ Á¦ÈÞ µîÀÌ ÀÌ Áö¿ª ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃã¼³Á¤ ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç ¹× Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¿Ü°ú¿ë ·Îº¿ ½Ã½ºÅÛ
    • Á¤Çü¿Ü°ú¿ë ·Îº¿ ½Ã½ºÅÛ
    • ³ú½Å°æ ¿Ü°ú ·Îº¿ ½Ã½ºÅÛ
    • ÀϹÝÀûÀÎ º¹°­°æ ·Îº¿ ½Ã½ºÅÛ
    • Á¶Á¾ °¡´ÉÇÑ ·Îº¿ Ä«Å×ÅÍ
  • ÀçȰ ·Îº¿ ½Ã½ºÅÛ
  • ºñħ½À¼º ¹æ»ç¼± ¼ö¼ú ·Îº¿
  • º´¿ø ¹× ¾à±¹ ·Îº¿ ½Ã½ºÅÛ
  • Ŭ¸°·ë ·Îº¿
  • ·Îº¿ ÀÇÁö
  • ¿¢¼Ò·Îº¿
  • ±âŸ Á¦Ç° À¯Çü

Á¦6Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : À¯Çüº°

  • Á¾·¡ÀÇ ·Îº¿
  • Çùµ¿ ·Îº¿
  • ±âŸ À¯Çü

Á¦7Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • À̵¿ ½Ã½ºÅÛ
  • ½Ã°¢È­ ½Ã½ºÅÛ
  • ¾ÈÀü ½Ã½ºÅÛ
  • ¼ÒÇÁÆ®¿þ¾î Ç÷§Æû
  • »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º
  • Àü¿ø
  • ±âŸ ÄÄÆ÷³ÍÆ®

Á¦8Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : Àü°³ À¯Çüº°

  • ¿ÂÇÁ·¹¹Ì½º
  • Ŭ¶ó¿ìµå ±â¹Ý

Á¦9Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : ¼­ºñ½ºº°

  • ±â±â ¹× ºÎ¼Óǰ
  • ÀÇ·á ¼­ºñ½º

Á¦10Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

  • ½Å°æÇÐ
  • ½ÉÀ庴ÇÐ
  • Á¤Çü¿Ü°ú
  • ºñ´¢±â°ú
  • ¾à±¹
  • ½Åü ÀçȰ
  • ºÎÀΰú
  • º¹°­°æ °Ë»ç
  • ¹æ»ç¼± Ä¡·á
  • Ưº°±³À°
  • ±âŸ ¿ëµµ

Á¦11Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ÀçȰ¼¾ÅÍ
  • ¾à±¹
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦12Àå ¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦13Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛÅõÀÚ(JV)
  • Àμö ¹× ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦14Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Hitachi Medical Systems
  • Auris Surgical Robotics Inc.(Hansen Medical Inc.)
  • Mako Surgical Corp.
  • Omnicell Technologies
  • Medtronic
  • Renishaw Plc
  • Accuray Incorporated
  • Intuitive Surgical Inc.
  • Siemens Healthineers AG
  • Mazor Robotics Ltd
  • iRobot Corporation
  • Stryker Corporation
  • Titan Medical Inc.
  • Varian Medical Systems
  • Smith & Nephew PLC
AJY 24.06.25

According to Stratistics MRC, the Global Medical Robotic System Market is accounted for $29.97 billion in 2024 and is expected to reach $84.68 billion by 2030 growing at a CAGR of 18.9% during the forecast period. Medical robotic systems are a revolutionary fusion of technology and healthcare that will completely change how procedures are carried out and treatments are given. These advanced devices are made to help surgeons perform complex procedures with greater accuracy and dexterity than is humanly possible, all while lowering patient risks. Moreover, medical robots can navigate delicate anatomical structures with unparalleled accuracy thanks to their advanced sensors, imaging technologies, and AI algorithms.

According to the International Federation of Robotics (IFR), the adoption of medical robotics is rapidly expanding, with an estimated 17,000 units of surgical robots installed worldwide by the end of 2020.

Market Dynamics:

Driver:

Growing requirement for less invasive surgery

Reduction in pain, shorter hospital stays, quicker recovery periods, and smaller incisions that leave fewer scars are just a few advantages that minimally invasive surgeries have over open procedures. There is a growing demand for medical robotic systems because they allow surgeons to perform these procedures with greater control and precision. Additionally, medical professionals are investing in robotically assisted surgical systems in response to patient demand for less invasive procedures, which is on the rise.

Restraint:

High starting prices

The high initial costs of medical robotic systems are one of the main obstacles preventing their widespread adoption. For healthcare facilities, the initial cost of purchasing robotic surgical systems, in addition to related training and maintenance costs can be significant. The expense burden is further increased by the requirement for specialized infrastructure and regular software updates. Furthermore, these exorbitant expenses are a major deterrent to investing in robotic technologies, especially for smaller healthcare providers or those working in resource-constrained environments.

Opportunity:

Innovations in technology and scientific progress

The medical robotic system market has a lot of potential due to ongoing advancements in robotic technology, which include the creation of smaller, more nimble robotic platforms, improved imaging modalities, and AI-driven surgical assistance. Technology companies, healthcare facilities, and research groups working together make it easier to discover new uses for robotic platforms already in use and to improve them. Moreover, the market for medical robotic systems is also evolving as a result of investments in research and development (R&D) projects that enhance surgical methods, increase the capabilities of medical robots, and investigate novel therapeutic areas.

Threat:

Market saturation and competition

The market for medical robotic systems is getting more and more competitive as more businesses enter the market and offer comparable technologies. The possibility of market saturation, in which the supply of medical robotic systems exceeds the demand, arises as a consequence. Price wars, shrinking profit margins, and decreased profitability for suppliers and manufacturers are all consequences of intense competition. Additionally, the dominance of medical robotic systems in some specialties is threatened by the spread of alternative surgical techniques and technologies like image-guided interventions and laparoscopic surgery.

Covid-19 Impact:

The market for medical robotic systems has been affected by the COVID-19 pandemic in a number of ways. A temporary slowdown in market growth was caused by the initial phase of the pandemic, which caused disruptions in manufacturing, supply chain logistics, and elective surgical procedures. However, the adoption of robotic-assisted surgeries has accelerated due to the need for social distancing and the subsequent emphasis on infection control measures. Healthcare facilities have been using robotic systems more and more to improve surgical precision, reduce the risk of viral transmission, and preserve personal protective equipment.

The Software Platform segment is expected to be the largest during the forecast period

The medical robotic system market is usually dominated by the software platform segment. This is so that data processing, robotic movement control, and hardware-to-hardware communication are all made possible by the software platform, which forms the core of medical robotic systems. These platforms enable precise surgical navigation, planning, and execution through the use of cutting-edge algorithms, artificial intelligence (AI), and machine learning capabilities. Furthermore, software platforms are essential for improving workflow efficiency, guaranteeing patient safety during robotically assisted procedures, and improving the user experience.

The Cloud Based segment is expected to have the highest CAGR during the forecast period

In the medical robotic system market, the cloud-based segment usually has the highest CAGR. Cloud-based solutions are becoming more and more appealing to medical device manufacturers and healthcare providers due to their many benefits, which include scalability, flexibility, and accessibility. Moreover, cloud-based medical robotic systems improve productivity, connectivity, and patient care delivery by enabling real-time data sharing, remote monitoring, and collaborative workflows.

Region with largest share:

In the medical robotic system market, North America usually holds the largest share. This dominance is ascribed to elements like the existence of a sophisticated healthcare infrastructure, high healthcare costs, advantageous reimbursement practices, and a strong regulatory environment that fosters the uptake of medical robotic systems. Additionally, the area also gains from a robust ecosystem of healthcare providers, research institutes, and technology companies that foster innovation and market expansion. Due to the extensive use of robotic-assisted surgeries in a variety of specialties, including gynecology, general surgery, and urology, the United States holds a sizable share of the market.

Region with highest CAGR:

In the medical robotic system market, Asia-Pacific usually has the highest CAGR. A growing awareness of advanced treatment options, rising disposable incomes, investments in medical technology, and a quickly growing healthcare infrastructure are some of the factors driving this growth. The Asia-Pacific region, which includes China, Japan, South Korea, and India, is seeing a sharp increase in the demand for medical robotic systems due to the growing prevalence of chronic illnesses, an aging population, and a move toward minimally invasive surgical procedures. Moreover, encouraging government programs, helpful laws, and alliances between foreign producers and regional healthcare providers all contribute to the market's expansion in the area.

Key players in the market

Some of the key players in Medical Robotic System market include Hitachi Medical Systems, Auris Surgical Robotics Inc. (Hansen Medical Inc.), Mako Surgical Corp., Omnicell Technologies, Medtronic, Renishaw Plc, Accuray Incorporated, Intuitive Surgical Inc., Siemens Healthineers AG, Mazor Robotics Ltd, iRobot Corporation, Stryker Corporation, Titan Medical Inc., Varian Medical Systems and Smith & Nephew PLC.

Key Developments:

In May 2024, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions that help improve patient outcomes worldwide. As the two companies sign a new agreement, we look back on their achievements, and their continuing impact on diagnostics and beyond.

In December 2023, Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.

In August 2023, Siemens Healthineers is teaming up with Catholic non-profit health care system SSM Health in a new 10-year strategic partnership aimed at advancing access to high-quality care and training of health care workers in the Midwest region of the US.

Product Types Covered:

  • Surgical Robotic Systems
  • Rehabilitative Robotic Systems
  • Non-invasive Radiosurgery Robots
  • Hospital and Pharmacy Robotic Systems
  • Clean Room Robots
  • Robotic Prosthetics
  • Exo-Robots
  • Other Product Types

Types Covered:

  • Traditional Robots
  • Collaborative Robots
  • Other Types

Components Covered:

  • Locomotion Systems
  • Visualization System
  • Safety Systems
  • Software Platform
  • User Interface
  • Power Sources
  • Other Components

Deployment Types Covered:

  • On-Premises
  • Cloud Based

Services Covered:

  • Instrument and Accessories
  • Medical Service

Applications Covered:

  • Neurology
  • Cardiology
  • Orthopedics
  • Urology
  • Pharmacy
  • Physical Rehabilitation
  • Gynecology
  • Laparoscopy
  • Radiation Therapy
  • Special Education
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Rehabilitation Centers
  • Pharmacy
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Robotic System Market, By Product Type

  • 5.1 Introduction
  • 5.2 Surgical Robotic Systems
    • 5.2.1 Orthopedic Robotic Systems
    • 5.2.2 Neurosurgery Robotic Systems
    • 5.2.3 General Laparoscopy Robotic Systems
    • 5.2.4 Steerable Robotic Catheters
  • 5.3 Rehabilitative Robotic Systems
  • 5.4 Non-invasive Radiosurgery Robots
  • 5.5 Hospital and Pharmacy Robotic Systems
  • 5.6 Clean Room Robots
  • 5.7 Robotic Prosthetics
  • 5.8 Exo-Robots
  • 5.9 Other Product Types

6 Global Medical Robotic System Market, By Type

  • 6.1 Introduction
  • 6.2 Traditional Robots
  • 6.3 Collaborative Robots
  • 6.4 Other Types

7 Global Medical Robotic System Market, By Component

  • 7.1 Introduction
  • 7.2 Locomotion Systems
  • 7.3 Visualization System
  • 7.4 Safety Systems
  • 7.5 Software Platform
  • 7.6 User Interface
  • 7.7 Power Sources
  • 7.8 Other Components

8 Global Medical Robotic System Market, By Deployment Type

  • 8.1 Introduction
  • 8.2 On-Premises
  • 8.3 Cloud Based

9 Global Medical Robotic System Market, By Service

  • 9.1 Introduction
  • 9.2 Instrument and Accessories
  • 9.3 Medical Service

10 Global Medical Robotic System Market, By Application

  • 10.1 Introduction
  • 10.2 Neurology
  • 10.3 Cardiology
  • 10.4 Orthopedics
  • 10.5 Urology
  • 10.6 Pharmacy
  • 10.7 Physical Rehabilitation
  • 10.8 Gynecology
  • 10.9 Laparoscopy
  • 10.10 Radiation Therapy
  • 10.11 Special Education
  • 10.12 Other Applications

11 Global Medical Robotic System Market, By End User

  • 11.1 Introduction
  • 11.2 Hospitals
  • 11.3 Ambulatory Surgical Centers
  • 11.4 Rehabilitation Centers
  • 11.5 Pharmacy
  • 11.6 Other End Users

12 Global Medical Robotic System Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Hitachi Medical Systems
  • 14.2 Auris Surgical Robotics Inc. (Hansen Medical Inc.)
  • 14.3 Mako Surgical Corp.
  • 14.4 Omnicell Technologies
  • 14.5 Medtronic
  • 14.6 Renishaw Plc
  • 14.7 Accuray Incorporated
  • 14.8 Intuitive Surgical Inc.
  • 14.9 Siemens Healthineers AG
  • 14.10 Mazor Robotics Ltd
  • 14.11 iRobot Corporation
  • 14.12 Stryker Corporation
  • 14.13 Titan Medical Inc.
  • 14.14 Varian Medical Systems
  • 14.15 Smith & Nephew PLC
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦